Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
All India Institute of Ayurveda hosts ministers and showcase their achievements
Advances deployment of mRNA technology across vaccines and therapeutics development
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
It had an estimated market size of US $ 32 million as of June 2021
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
It works as an adjunct to standard care based on robust clinical trials
Subscribe To Our Newsletter & Stay Updated